Wang Y et al. |
LC, a novel estrone-rhein hybrid compound, concurrently stimulates osteoprotegerin and inhibits receptor activator of NF-κB ligand (RANKL) and interleukin-6 production by human osteoblastic cells. |
2011 |
Mol. Cell. Endocrinol. |
pmid:21291955
|
Szulc P et al. |
Cortical bone status is associated with serum osteoprotegerin concentration in men: the STRAMBO study. |
2011 |
J. Clin. Endocrinol. Metab. |
pmid:21565793
|
Chang YC and Zhao JH |
Effects of platelet-rich fibrin on human periodontal ligament fibroblasts and application for periodontal infrabony defects. |
2011 |
Aust Dent J |
pmid:22126345
|
Yang L et al. |
Osteoprotegerin and osteoprotegerin ligand expression during human marrow stromal cell differentiation and their effect on osteoclast formation. |
2011 |
Chin. Med. J. |
pmid:22088466
|
Curl L and Sampson W |
The presence of TNF-alpha and TNFR1 in aseptic root resorption. A preliminary study. |
2011 |
Aust Orthod J |
pmid:22372265
|
Ibrahim T et al. |
Role of RANK, RANKL, OPG, and CXCR4 tissue markers in predicting bone metastases in breast cancer patients. |
2011 |
Clin. Breast Cancer |
pmid:21764390
|
Yamamoto K et al. |
Effects of mechanical stress on cytokine production in mandible-derived osteoblasts. |
2011 |
Oral Dis |
pmid:21771211
|
Chen WJ et al. |
Association of plasma osteoprotegerin and adiponectin with arterial function, cardiac function and metabolism in asymptomatic type 2 diabetic men. |
2011 |
Cardiovasc Diabetol |
pmid:21771299
|
Pepene CE et al. |
Elevated serum receptor activator of nuclear factor kappa B ligand and osteoprotegerin levels in late-onset male hypogonadism. |
2011 |
Clin Invest Med |
pmid:21810381
|
Sheng L et al. |
[Inhibitory acting mechanism of psoralen-osthole on bone metastasis of breast cancer--an expatiation viewing from OPG/RANKL/RANK system]. |
2011 |
Zhongguo Zhong Xi Yi Jie He Za Zhi |
pmid:21812275
|
Yang XY et al. |
[Influence of surface modification of titanium on OPG/RANKL mRNA expression in MG-63 human osteoblast-like cells]. |
2011 |
Nan Fang Yi Ke Da Xue Xue Bao |
pmid:21868322
|
Malliga DE et al. |
The role of osteoprotegerin (OPG) receptor activator for nuclear factor kappaB ligand (RANKL) in cardiovascular pathology - a review. |
2011 |
Wien Med Wochenschr |
pmid:21870142
|
Guo HL et al. |
[Experimental study on the mechanism of icariin improving human osteoblasts proliferation and the expression of OPG protein]. |
2011 |
Zhongguo Gu Shang |
pmid:21870401
|
Loncar G et al. |
Association of increased parathyroid hormone with neuroendocrine activation and endothelial dysfunction in elderly men with heart failure. |
2011 |
J. Endocrinol. Invest. |
pmid:20820131
|
Tripathi A et al. |
Bisphosphonate therapy for skeletal malignancies and metastases: impact on jaw bones and prosthodontic concerns. |
2011 |
J Prosthodont |
pmid:21883630
|
Mohamed GB and Abdel-Latif EA |
Serum osteoprotegerin (OPG) in children with primary nephrotic syndrome. |
2011 |
Saudi J Kidney Dis Transpl |
pmid:21912025
|
Lommi JI et al. |
High-density lipoproteins (HDL) are present in stenotic aortic valves and may interfere with the mechanisms of valvular calcification. |
2011 |
Atherosclerosis |
pmid:21917259
|
Embree M et al. |
Role of subchondral bone during early-stage experimental TMJ osteoarthritis. |
2011 |
J. Dent. Res. |
pmid:21917603
|
Hope S et al. |
Affective symptoms are associated with markers of inflammation and immune activation in bipolar disorders but not in schizophrenia. |
2011 |
J Psychiatr Res |
pmid:21889167
|
Shin M et al. |
The inhibition of RANKL/RANK signaling by osteoprotegerin suppresses bone invasion by oral squamous cell carcinoma cells. |
2011 |
Carcinogenesis |
pmid:21890459
|
Giner M et al. |
Alendronate and raloxifene affect the osteoprotegerin/RANKL system in human osteoblast primary cultures from patients with osteoporosis and osteoarthritis. |
2011 |
Eur. J. Pharmacol. |
pmid:21050847
|
Grigoropoulou P et al. |
The role of the osteoprotegerin/RANKL/RANK system in diabetic vascular disease. |
2011 |
Curr. Med. Chem. |
pmid:21919846
|
To M et al. |
Osteoprotegerin in sputum is a potential biomarker in COPD. |
2011 |
Chest |
pmid:21127170
|
Witasp A et al. |
Expression of osteoprotegerin in human fat tissue; implications for chronic kidney disease. |
2011 |
Eur. J. Clin. Invest. |
pmid:21128937
|
Khoshniat S et al. |
Phosphate-dependent stimulation of MGP and OPN expression in osteoblasts via the ERK1/2 pathway is modulated by calcium. |
2011 |
Bone |
pmid:21147284
|
Durual S et al. |
Titanium nitride oxide coating on rough titanium stimulates the proliferation of human primary osteoblasts. |
2011 |
Clin Oral Implants Res |
pmid:21087318
|
Ashley DT et al. |
Similar to adiponectin, serum levels of osteoprotegerin are associated with obesity in healthy subjects. |
2011 |
Metab. Clin. Exp. |
pmid:21087777
|
Tekkesin MS et al. |
The role of RANK/RANKL/OPG signalling pathways in osteoclastogenesis in odontogenic keratocysts, radicular cysts, and ameloblastomas. |
2011 |
Head Neck Pathol |
pmid:21643971
|
Jiang JQ et al. |
Serum osteoprotegerin measurement for early diagnosis of chronic kidney disease-mineral and bone disorder. |
2011 |
Nephrology (Carlton) |
pmid:21649792
|
Hossein-nezhad A et al. |
The influence of folic acid supplementation on maternal and fetal bone turnover. |
2011 |
J. Bone Miner. Metab. |
pmid:20602129
|
Schoppet M et al. |
Crystallizing nanoparticles derived from vascular smooth muscle cells contain the calcification inhibitor osteoprotegerin. |
2011 |
Biochem. Biophys. Res. Commun. |
pmid:21371424
|
Pobeha P et al. |
Relationship between osteoporosis and adipose tissue leptin and osteoprotegerin in patients with chronic obstructive pulmonary disease. |
2011 |
Bone |
pmid:21376149
|
Colombini A et al. |
Plasma and drainage fluid levels of soluble receptor activator of nuclear factor-kB (sRANK), soluble receptor activator of nuclear factor-kB ligand (sRANKL) and osteoprotegerin (OPG) during proximal humerus fracture healing. |
2011 |
Int Orthop |
pmid:20623281
|
Krause U et al. |
Assays of osteogenic differentiation by cultured human mesenchymal stem cells. |
2011 |
Methods Mol. Biol. |
pmid:21431522
|
Clemens TL and Karsenty G |
The osteoblast: an insulin target cell controlling glucose homeostasis. |
2011 |
J. Bone Miner. Res. |
pmid:21433069
|
Galliera E et al. |
Circulating OPG levels are reduced following infliximab treatment and correlate with CRP levels: is serum OPG a potential marker of IBD disease activity? |
2011 |
Inflamm. Bowel Dis. |
pmid:21433226
|
Hou L et al. |
Effects of osteoprotegerin from transfection of pcDNA3.1(+)/chOPG on bioactivity of chicken osteoclasts. |
2011 |
Acta Vet. Scand. |
pmid:21435269
|
Baloul SS et al. |
Mechanism of action and morphologic changes in the alveolar bone in response to selective alveolar decortication-facilitated tooth movement. |
2011 |
Am J Orthod Dentofacial Orthop |
pmid:21435543
|
Wang AY |
Consequences of chronic inflammation in peritoneal dialysis. |
2011 |
Semin. Nephrol. |
pmid:21439430
|
Ikeda K et al. |
Conditional expression of constitutively active estrogen receptor α in osteoblasts increases bone mineral density in mice. |
2011 |
FEBS Lett. |
pmid:21439958
|
Teramachi J et al. |
Adenosine abolishes MTX-induced suppression of osteoclastogenesis and inflammatory bone destruction in adjuvant-induced arthritis. |
2011 |
Lab. Invest. |
pmid:21339747
|
Katz J et al. |
Genetic polymorphisms and other risk factors associated with bisphosphonate induced osteonecrosis of the jaw. |
2011 |
Int J Oral Maxillofac Surg |
pmid:21396799
|
Vishvanath A et al. |
Infantile haemangioma expresses tumour necrosis factor-related apoptosis-inducing ligand (TRAIL), TRAIL receptors, osteoprotegerin and receptor activator for nuclear factor кB ligand (RANKL). |
2011 |
Histopathology |
pmid:22034880
|
Vidal C et al. |
Functional polymorphisms within the TNFRSF11B (osteoprotegerin) gene increase the risk for low bone mineral density. |
2011 |
J. Mol. Endocrinol. |
pmid:21994215
|
Hemingway F et al. |
In vitro generation of mature human osteoclasts. |
2011 |
Calcif. Tissue Int. |
pmid:21960377
|
Dimitriadis K et al. |
Exercise blood pressure response is related to asymmetric dimethylarginine and osteoprotegerin in hypertension. |
2011 |
Int. J. Cardiol. |
pmid:21975354
|
Yao Y et al. |
Synergistic enhancement of new bone formation by recombinant human bone morphogenetic protein-2 and osteoprotegerin in trans-sutural distraction osteogenesis: a pilot study in dogs. |
2011 |
J. Oral Maxillofac. Surg. |
pmid:22018252
|
Brown TT et al. |
Bone turnover, osteoprotegerin/RANKL and inflammation with antiretroviral initiation: tenofovir versus non-tenofovir regimens. |
2011 |
Antivir. Ther. (Lond.) |
pmid:22024522
|
Mödder UI et al. |
Regulation of circulating sclerostin levels by sex steroids in women and in men. |
2011 |
J. Bone Miner. Res. |
pmid:20499362
|
Kaneuji T et al. |
Mechanisms involved in regulation of osteoclastic differentiation by mechanical stress-loaded osteoblasts. |
2011 |
Biochem. Biophys. Res. Commun. |
pmid:21459078
|
Luvizuto ER et al. |
Raloxifene therapy inhibits osteoclastogenesis during the alveolar healing process in rats. |
2011 |
Arch. Oral Biol. |
pmid:21536255
|
Hsieh TP et al. |
Icariin inhibits osteoclast differentiation and bone resorption by suppression of MAPKs/NF-κB regulated HIF-1α and PGE(2) synthesis. |
2011 |
Phytomedicine |
pmid:20554188
|
Al-Dujaili SA et al. |
Apoptotic osteocytes regulate osteoclast precursor recruitment and differentiation in vitro. |
2011 |
J. Cell. Biochem. |
pmid:21538477
|
Stępień E et al. |
Increased levels of bone remodeling biomarkers (osteoprotegerin and osteopontin) in hypertensive individuals. |
2011 |
Clin. Biochem. |
pmid:21539822
|
Zheng Y et al. |
Vitamin D deficiency promotes prostate cancer growth in bone. |
2011 |
Prostate |
pmid:21541977
|
Yener S et al. |
Is there an association between non-functioning adrenal adenoma and endothelial dysfunction? |
2011 |
J. Endocrinol. Invest. |
pmid:20530985
|
de Souza JA et al. |
Expression of suppressor of cytokine signaling 1 and 3 in ligature-induced periodontitis in rats. |
2011 |
Arch. Oral Biol. |
pmid:21511249
|
Claro T et al. |
Staphylococcus aureus protein A binds to osteoblasts and triggers signals that weaken bone in osteomyelitis. |
2011 |
PLoS ONE |
pmid:21525984
|
Giro G et al. |
Influence of estrogen deficiency on bone around osseointegrated dental implants: an experimental study in the rat jaw model. |
2011 |
J. Oral Maxillofac. Surg. |
pmid:21530046
|
Won KY et al. |
RANK signalling in bone lesions with osteoclast-like giant cells. |
2011 |
Pathology |
pmid:21532526
|
Naot D et al. |
Molecular mechanisms involved in the mitogenic effect of lactoferrin in osteoblasts. |
2011 |
Bone |
pmid:21515435
|
Xu ML et al. |
[An update for the research progress of osteoprotegerin on coronary artery disease]. |
2011 |
Zhonghua Xin Xue Guan Bing Za Zhi |
pmid:22321243
|
Karosi T et al. |
Osteoprotegerin expression and sensitivity in otosclerosis with different histological activity. |
2011 |
Eur Arch Otorhinolaryngol |
pmid:20963600
|
Halade GV et al. |
Obesity-mediated inflammatory microenvironment stimulates osteoclastogenesis and bone loss in mice. |
2011 |
Exp. Gerontol. |
pmid:20923699
|
Mitsuhashi M et al. |
Effects of HSP70 on the compression force-induced TNF-α and RANKL expression in human periodontal ligament cells. |
2011 |
Inflamm. Res. |
pmid:20924639
|
Huang CH et al. |
Osteoprotegerin genetic polymorphisms and age of symptom onset in ankylosing spondylitis. |
2011 |
Rheumatology (Oxford) |
pmid:20974615
|
Pepene CE et al. |
Circulating osteoprotegerin and soluble receptor activator of nuclear factor κB ligand in polycystic ovary syndrome: relationships to insulin resistance and endothelial dysfunction. |
2011 |
Eur. J. Endocrinol. |
pmid:20974706
|
Kassi E et al. |
Effects of Sideritis euboea (Lamiaceae) aqueous extract on IL-6, OPG and RANKL secretion by osteoblasts. |
2011 |
Nat Prod Commun |
pmid:22224290
|
Sipos W et al. |
OPG-Fc treatment in growing pigs leads to rapid reductions in bone resorption markers, serum calcium, and bone formation markers. |
2011 |
Horm. Metab. Res. |
pmid:22161252
|
Sobue T et al. |
Murine TMJ loading causes increased proliferation and chondrocyte maturation. |
2011 |
J. Dent. Res. |
pmid:21248355
|
Ribeiro FV et al. |
Cytokines and bone-related factors in systemically healthy patients with chronic periodontitis and patients with type 2 diabetes and chronic periodontitis. |
2011 |
J. Periodontol. |
pmid:21284550
|
Vik A et al. |
Serum osteoprotegerin is a predictor for incident cardiovascular disease and mortality in a general population: the Tromsø Study. |
2011 |
J. Thromb. Haemost. |
pmid:21284802
|
Akinci B et al. |
Increased osteoprotegerin levels in women with previous gestational diabetes developing metabolic syndrome. |
2011 |
Diabetes Res. Clin. Pract. |
pmid:20970873
|
Hasegawa T et al. |
[Animal models for bone and joint disease. Bone disease of osteoprotegerin deficient mouse]. |
2011 |
Clin Calcium |
pmid:21289415
|
Toffoli B et al. |
Osteoprotegerin induces morphological and functional alterations in mouse pancreatic islets. |
2011 |
Mol. Cell. Endocrinol. |
pmid:20832449
|
Qu Z et al. |
Effect of enamel matrix derivative on proliferation and differentiation of osteoblast cells grown on the titanium implant surface. |
2011 |
Oral Surg Oral Med Oral Pathol Oral Radiol Endod |
pmid:21232997
|
Rauch A et al. |
An anti-inflammatory selective glucocorticoid receptor modulator preserves osteoblast differentiation. |
2011 |
FASEB J. |
pmid:21233489
|
Ueland T et al. |
Osteoprotegerin predicts progression of chronic heart failure: results from CORONA. |
2011 |
Circ Heart Fail |
pmid:21216833
|
Tang T et al. |
Effect of water-soluble P-chitosan and S-chitosan on human primary osteoblasts and giant cell tumor of bone stromal cells. |
2011 |
Biomed Mater |
pmid:21205994
|
Attia EA et al. |
Assessment of osteoporosis in psoriasis with and without arthritis: correlation with disease severity. |
2011 |
Int. J. Dermatol. |
pmid:21182499
|
Jabbar S et al. |
Osteoprotegerin, RANKL and bone turnover in postmenopausal osteoporosis. |
2011 |
J. Clin. Pathol. |
pmid:21307155
|
Maïmoun L et al. |
In peripubertal girls, artistic gymnastics improves areal bone mineral density and femoral bone geometry without affecting serum OPG/RANKL levels. |
2011 |
Osteoporos Int |
pmid:21359671
|
Polzer K et al. |
Proteasome inhibition aggravates tumor necrosis factor-mediated bone resorption in a mouse model of inflammatory arthritis. |
2011 |
Arthritis Rheum. |
pmid:21360496
|
Oshita K et al. |
Human mesenchymal stem cells inhibit osteoclastogenesis through osteoprotegerin production. |
2011 |
Arthritis Rheum. |
pmid:21360521
|
Wang SY et al. |
Circulating Dickkopf-1 is correlated with bone erosion and inflammation in rheumatoid arthritis. |
2011 |
J. Rheumatol. |
pmid:21362762
|
Preshaw PM and Taylor JJ |
How has research into cytokine interactions and their role in driving immune responses impacted our understanding of periodontitis? |
2011 |
J. Clin. Periodontol. |
pmid:21323705
|
Sun CX et al. |
[Patterns of osteoprotegerin or nuclear factor kappa B ligand gene expression in the treatment of bone defect with bone marrow stem cell transplantation and low-frequency vibration]. |
2011 |
Zhonghua Yi Xue Za Zhi |
pmid:21600122
|
Basu R et al. |
Effects of physiological variations in circulating insulin levels on bone turnover in humans. |
2011 |
J. Clin. Endocrinol. Metab. |
pmid:21325461
|
Liu ZF et al. |
[Effect of ultrasound on osteoprotegerin and receptor activator nuclear factor kappaB ligand expression during root resorption in rats]. |
2011 |
Nan Fang Yi Ke Da Xue Xue Bao |
pmid:21602131
|
Kamiya N et al. |
Significance of serum osteoprotegerin and receptor activator of nuclear factor κB ligand in Japanese prostate cancer patients with bone metastasis. |
2011 |
Int. J. Clin. Oncol. |
pmid:21327451
|
Eslami B et al. |
Reduced osteoclastogenesis and RANKL expression in marrow from women taking alendronate. |
2011 |
Calcif. Tissue Int. |
pmid:21327765
|
Blázquez-Medela AM et al. |
Osteoprotegerin and diabetes-associated pathologies. |
2011 |
Curr. Mol. Med. |
pmid:21568931
|
Jørgensen L et al. |
Serum osteoprotegerin levels are related to height loss: the Tromsø Study. |
2011 |
Eur. J. Epidemiol. |
pmid:21331661
|
Yuan H et al. |
Receptor activator of nuclear factor kappa B ligand antagonists inhibit tissue inflammation and bone loss in experimental periodontitis. |
2011 |
J. Clin. Periodontol. |
pmid:22092474
|
Feng Z et al. |
An oligodeoxynucleotide with promising modulation activity for the proliferation and activation of osteoblast. |
2011 |
Int J Mol Sci |
pmid:21731457
|
Peng S et al. |
Osteoprotegerin deficiency attenuates strontium-mediated inhibition of osteoclastogenesis and bone resorption. |
2011 |
J. Bone Miner. Res. |
pmid:21611968
|
Mai QG et al. |
Metformin stimulates osteoprotegerin and reduces RANKL expression in osteoblasts and ovariectomized rats. |
2011 |
J. Cell. Biochem. |
pmid:21618594
|
Kornak U |
Animal models with pathological mineralization phenotypes. |
2011 |
Joint Bone Spine |
pmid:21550285
|
Santini D et al. |
Receptor activator of NF-kB (RANK) expression in primary tumors associates with bone metastasis occurrence in breast cancer patients. |
2011 |
PLoS ONE |
pmid:21559440
|
Mariúba MV et al. |
Effect of triiodothyronine on the maxilla and masseter muscles of the rat stomatognathic system. |
2011 |
Braz. J. Med. Biol. Res. |
pmid:21584440
|